Bolt Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Bolt Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Bolt Biotherapeutics Inc
Rating: 2.09141675
Author: Trendlyne DVM scores

about

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

6.68 0.43 (6.88%)

39.93% Fall from 52W High

14,420

XNAS Volume

XNAS 23 Jan, 2026 3:13 PM (EST)

Not Eligible

Expensive Valuation

29.2 / 100

Technically Neutral

54.5 / 100

1Yr Price target upside is 229%

4 analysts

Bolt Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bolt Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

39.93% Fall from 52W High

SWOT Analysis

Bolt Biotherapeutics Inc Live Price Chart